Drug Patent Expirations in April 2010
Drug Patent Expirations in April 2010
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
|---|---|---|---|---|
| HYZAAR | Merck | hydrochlorothiazide; losartan potassium | 5,153,197*PED | Apr 6, 2010 |
| IPLEX | Insmed | mecasermin rinfabate recombinant | 5,200,509 | Apr 6, 2010 |
| COZAAR | Merck | losartan potassium | 5,153,197*PED | Apr 6, 2010 |
| DUODOTE | Meridian Medcl | atropine; pralidoxime chloride | 5,092,843 | Apr 12, 2010 |
| EMBEDA | Alpharma King | morphine sulfate; naltrexone hydrochloride | 5,202,128 | Apr 13, 2010 |
| KADIAN | Actavis Elizabeth | morphine sulfate | 5,202,128 | Apr 13, 2010 |
| MUSE | Vivus | alprostadil | 5,773,020 | Apr 25, 2010 |
| FLOMAX | Boehringer Ingelheim | tamsulosin hydrochloride | 4,703,063*PED | Apr 27, 2010 |
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.Courtesy of DrugPatentWatch.com
Leave a Reply
Want to join the discussion?Feel free to contribute!